Literature DB >> 28652400

Activation of Human Basophils by A549 Lung Epithelial Cells Reveals a Novel IgE-Dependent Response Independent of Allergen.

John T Schroeder1, Anja P Bieneman2.   

Abstract

Evidence for epithelial cell (EC)-derived cytokines (e.g., thymic stromal lymphopoietin [TSLP]) activating human basophils remains controversial. We therefore hypothesize that ECs can directly activate basophils via cell-to-cell interaction. Basophils in medium alone or with IL-3 ± anti-IgE were coincubated with TSLP, IL-33, or IL-25. Analogous experiments cocultured basophils (1-72 h) directly with EC lines. Supernatants were tested for mediators and cytokines. Abs targeting receptors were tested for neutralizing effects. Lactic acid (pH 3.9) treatment combined with passive sensitization tested the role of IgE. Overall, IL-33 augmented IL-13 secretion from basophils cotreated with IL-3, with minimal effects on histamine and IL-4. Conversely, basophils (but not mast cells) released histamine and marked levels of IL-4/IL-13 (10-fold) when cocultured with A549 EC and IL-3, without exogenous allergen or IgE cross-linking stimuli. The inability to detect IL-33 or TSLP, or to neutralize their activity, suggested a unique mode of basophil activation by A549 EC. Half-maximal rates for histamine (4 h) and IL-4 (5 h) secretion were slower than observed with standard IgE-dependent activation. Ig stripping combined with passive sensitization ± omalizumab showed a dependency for basophil-bound IgE, substantiated by a requirement for cell-to-cell contact, aggregation, and FcεRI-dependent signaling. A yet unidentified IgE-binding lectin associated with A549 EC is implicated after discovering that LacNAc suppressed basophil activation in cocultures. These findings point to a lectin-dependent activation of basophil requiring IgE but independent of allergen or secreted cytokine. Pending further investigation, we predict this unique mode of activation is linked to inflammatory conditions whereby IgE-dependent activation of basophils occurs despite the absence of any known allergen.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28652400      PMCID: PMC5541892          DOI: 10.4049/jimmunol.1700055

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  Galectin-3 and the skin.

Authors:  Larissa Larsen; Huan-Yuan Chen; Jun Saegusa; Fu-Tong Liu
Journal:  J Dermatol Sci       Date:  2011-08-11       Impact factor: 4.563

2.  Comparative analyses on expression of galectins1-4, 7-10 and 12 in first trimester placenta, decidua and isolated trophoblast cells in vitro.

Authors:  Laura Unverdorben; Udo Jeschke; Laura Santoso; Simone Hofmann; Christina Kuhn; Petra Arck; Stefan Hutter
Journal:  Histol Histopathol       Date:  2016-02-22       Impact factor: 2.303

Review 3.  Basophils and allergic inflammation.

Authors:  Mark C Siracusa; Brian S Kim; Jonathan M Spergel; David Artis
Journal:  J Allergy Clin Immunol       Date:  2013-10       Impact factor: 10.793

4.  Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin.

Authors:  Deepti R Nagarkar; Julie A Poposki; Michael R Comeau; Assel Biyasheva; Pedro C Avila; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2012-05-26       Impact factor: 10.793

5.  Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release.

Authors:  J J Pruzansky; L C Grammer; R Patterson; M Roberts
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

Review 6.  Galectin 3 as a guardian of the tumor microenvironment.

Authors:  Peter P Ruvolo
Journal:  Biochim Biophys Acta       Date:  2015-08-08

7.  Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis.

Authors:  Mario Noti; Brian S Kim; Mark C Siracusa; Gregory D Rak; Masato Kubo; Amin E Moghaddam; Quentin A Sattentau; Michael R Comeau; Jonathan M Spergel; David Artis
Journal:  J Allergy Clin Immunol       Date:  2014-02-20       Impact factor: 10.793

8.  IgE-activated basophils regulate eosinophil tissue entry by modulating endothelial function.

Authors:  Laurence E Cheng; Brandon M Sullivan; Lizett E Retana; Christopher D C Allen; Hong-Erh Liang; Richard M Locksley
Journal:  J Exp Med       Date:  2015-03-16       Impact factor: 14.307

9.  Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients.

Authors:  Lucia De Monte; Sonja Wörmann; Emanuela Brunetto; Silvia Heltai; Gilda Magliacane; Michele Reni; Anna Maria Paganoni; Helios Recalde; Anna Mondino; Massimo Falconi; Francesca Aleotti; Gianpaolo Balzano; Hana Algül; Claudio Doglioni; Maria Pia Protti
Journal:  Cancer Res       Date:  2016-02-12       Impact factor: 12.701

10.  Proteomics of bronchial biopsies: galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients.

Authors:  Pierluigi Mauri; Anna Maria Riccio; Rossana Rossi; Dario Di Silvestre; Louise Benazzi; Laura De Ferrari; Roberto Walter Dal Negro; Stephen T Holgate; Giorgio Walter Canonica
Journal:  Immunol Lett       Date:  2014-09-03       Impact factor: 3.685

View more
  13 in total

1.  Galectin-3 is essential for IgE-dependent activation of human basophils by A549 lung epithelial cells.

Authors:  John T Schroeder; Abiodun A Adeosun; Danh Do; Anja P Bieneman
Journal:  J Allergy Clin Immunol       Date:  2019-03-09       Impact factor: 10.793

Review 2.  Basophils as a potential therapeutic target in cancer.

Authors:  Jicheng Zhang; Hanlin Yin; Qiangda Chen; Guochao Zhao; Wenhui Lou; Wenchuan Wu; Ning Pu
Journal:  J Zhejiang Univ Sci B       Date:  2021-12-15       Impact factor: 3.066

3.  IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells.

Authors:  Remo Poto; Isabella Quinti; Gianni Marone; Maurizio Taglialatela; Amato de Paulis; Vincenzo Casolaro; Gilda Varricchi
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

Review 4.  Mechanisms of Allergen Immunotherapy in Allergic Rhinitis.

Authors:  Gabija Drazdauskaitė; Janice A Layhadi; Mohamed H Shamji
Journal:  Curr Allergy Asthma Rep       Date:  2020-12-12       Impact factor: 4.806

Review 5.  Basophils Orchestrating Eosinophils' Chemotaxis and Function in Allergic Inflammation.

Authors:  Joseena Iype; Michaela Fux
Journal:  Cells       Date:  2021-04-14       Impact factor: 6.600

Review 6.  Clinical and Translational Significance of Basophils in Patients with Cancer.

Authors:  Jitesh Chauhan; Chara Stavraka; Melanie Grandits; Lais C G F Palhares; Debra H Josephs; Katie E Lacy; James Spicer; Heather J Bax; Sophia N Karagiannis
Journal:  Cells       Date:  2022-01-27       Impact factor: 7.666

7.  The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3.

Authors:  John T Schroeder; Anja P Bieneman
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

8.  SARS-CoV-2 Induces Cytokine Responses in Human Basophils.

Authors:  Srinivasa Reddy Bonam; Camille Chauvin; Laurine Levillayer; Mano Joseph Mathew; Anavaj Sakuntabhai; Jagadeesh Bayry
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

Review 9.  Is There a Role for Basophils in Cancer?

Authors:  Giancarlo Marone; John T Schroeder; Fabrizio Mattei; Stefania Loffredo; Adriana Rosa Gambardella; Remo Poto; Amato de Paulis; Giovanna Schiavoni; Gilda Varricchi
Journal:  Front Immunol       Date:  2020-09-08       Impact factor: 7.561

10.  Epithelial Cell-Associated Galectin-3 Activates Human Dendritic Cell Subtypes for Pro-Inflammatory Cytokines.

Authors:  John T Schroeder; Abiodun A Adeosun; Anja P Bieneman
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.